Mesothelioma Info Article:
Does It Pay to Get a Mesothelioma Attorney?
Mesothelioma is a serious form of rare cancer. There is no known cure for mesothelioma cancer. If you or a loved one has been diagnosed with mesothelioma cancer you will no doubt have many questions and concerns and may have wondered if you need a mesothelioma attorney.
Although the number of people being newly exposed to the risk of mesothelioma cancer is now at a minimum, newly diagnosed cases of the disease are set to rise dramatically in the coming decades. This is due to the fact that symptoms can take 30 to 50 years to develop. Sufferers only become aware of symptoms once the mesothelioma cancer has reached an advanced stage, which is why the disease is so difficult to treat and has such a low survival rate once diagnosed. The has caused an increase in the need for a mesothelioma attorney in some parts of the country.
The average mesothelioma latency period is approximately 35 - 40 years. Occupational exposure to asbestos over the past fifty years in the United States is calculated to have occurred in approximately eight million people causing many to look for a mesothelioma attorney to handle their case.
Mesothelioma is the most lucrative type of asbestos claim. Such suits typically are settled out of court for about $3 million each, according to plaintiff and mesothelioma attorneys.
The current trend indicates that getting a Mesothelioma attorney may not be such a bad idea if you you have mesothelioma cancer.
Suggested Resources:
Related Mesothelioma News and Articles From yahoo-rss
Reuters - People who are obese are at increased risk of becoming depressed, and people who are depressed are at increased risk of becoming obese, Dutch researchers have found.
AFP - Former president Bill Clinton and Microsoft founder Bill Gates called Wednesday on US lawmakers to boost foreign aid to fight diseases like HIV/AIDS and malaria in the world's poorest nations.
AFP - AIDS 2010, the 18th International AIDS Conference being held in Vienna later this year, will focus on marginalised groups living with the disease, such as injecting drug users in Eastern Europe, organisers said Wednesday.
